Half of new US-approved drugs remain unavailable to Japanese patients
We haven't written up this one. Nikkei Asia has the full story — the link below goes straight to it.
What's breaking now, across thousands of outlets.
We haven't written up this one. Nikkei Asia has the full story — the link below goes straight to it.
Having cancer was unequivocally not a good thing, but there were good things about it. I can understand why people might want those things.
The Phase 3 findings suggested Kodiak might have multiple threats to Regeneron’s Eylea and added more than $3 billion to the company’s market value.
"Would you like your receipt?"
One of the puzzling aspects of endometriosis—a gynecologic condition in which tissue similar to that lining the uterus grows outside of it—is that the extent of the disease doesn't determine the…
A long-running UK study says irritability and anxiety – not attention problems – may be the connection between ADHD and depression.